×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SRTS – sensus healthcare, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SRTS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
08:17 am
srts
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer [Yahoo! Finance]
Low
Report
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer [Yahoo! Finance]
11/14
08:00 am
srts
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Medium
Report
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
11/12
08:00 am
srts
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
Medium
Report
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
11/9
07:03 pm
srts
US$7.50: That's What Analysts Think Sensus Healthcare, Inc. (NASDAQ:SRTS) Is Worth After Its Latest Results [Yahoo! Finance]
Medium
Report
US$7.50: That's What Analysts Think Sensus Healthcare, Inc. (NASDAQ:SRTS) Is Worth After Its Latest Results [Yahoo! Finance]
11/6
09:49 pm
srts
Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
04:05 pm
srts
Sensus Healthcare Reports Third Quarter 2025 Financial Results
High
Report
Sensus Healthcare Reports Third Quarter 2025 Financial Results
11/6
08:00 am
srts
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
Medium
Report
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
11/4
08:00 am
srts
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
High
Report
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
02:28 pm
srts
Form 4 Sensus Healthcare, Inc. For: Nov 21 Filed by: Sachetta Eric
Low
Report
Form 4 Sensus Healthcare, Inc. For: Nov 21 Filed by: Sachetta Eric
11/20
02:03 pm
srts
Form 4 Sensus Healthcare, Inc. For: Nov 13 Filed by: Sachetta Eric
Low
Report
Form 4 Sensus Healthcare, Inc. For: Nov 13 Filed by: Sachetta Eric
11/20
01:56 pm
srts
Form 3 Sensus Healthcare, Inc. For: Nov 10 Filed by: Sachetta Eric
Low
Report
Form 3 Sensus Healthcare, Inc. For: Nov 10 Filed by: Sachetta Eric
11/19
09:34 am
srts
Form 4 Sensus Healthcare, Inc. For: Nov 18 Filed by: Sardano Joseph C
Low
Report
Form 4 Sensus Healthcare, Inc. For: Nov 18 Filed by: Sardano Joseph C
11/19
09:15 am
srts
Form 4 Sensus Healthcare, Inc. For: Nov 18 Filed by: Sardano Michael
Low
Report
Form 4 Sensus Healthcare, Inc. For: Nov 18 Filed by: Sardano Michael
11/18
04:32 pm
srts
Form 4/A Sensus Healthcare, Inc. For: Nov 11 Filed by: Sardano Michael
Low
Report
Form 4/A Sensus Healthcare, Inc. For: Nov 11 Filed by: Sardano Michael
11/13
10:07 am
srts
Form 8-K Sensus Healthcare, Inc. For: Nov 10
Medium
Report
Form 8-K Sensus Healthcare, Inc. For: Nov 10
11/13
09:07 am
srts
Form 4/A Sensus Healthcare, Inc. For: Nov 11 Filed by: Sardano Michael
Medium
Report
Form 4/A Sensus Healthcare, Inc. For: Nov 11 Filed by: Sardano Michael
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/8
Q2/2019 6/30/2019 EPS 0.010 ZacksConsensus -0.030 ActVsEst 0.040 - Beat
9.3%
3/3 Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology 9.0%
1/16 Form 3 Sensus Healthcare, Inc. For: Jan 06 Filed by: Price Russ 3.9%
8/28 Sensus Healthcare Inc (NASDAQ: SRTS) was upgraded by analysts at TheStreet from a "d+" rating to a "c-" rating. 2.7%
5/12 Sensus Healthcare's (SRTS) CEO Joe Sardano on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 2.6%
8/12 Sensus Healthcare Inc (NASDAQ: SRTS) was given a new $11.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 2.6%
9/20 Sensus Healthcare Inc (NASDAQ: SRTS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 1.8%
10/18 Sensus Healthcare Inc (NASDAQ: SRTS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 1.8%
11/10 Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 1.6%
5/24 Sensus Healthcare Inc (NASDAQ: SRTS) was downgraded by analysts at TheStreet from a "c-" rating to a "d+" rating. 1.3%
3/3 Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology 9.0%
1/16 Form 3 Sensus Healthcare, Inc. For: Jan 06 Filed by: Price Russ 3.9%
8/28 Sensus Healthcare Inc (NASDAQ: SRTS) was upgraded by analysts at TheStreet from a "d+" rating to a "c-" rating. 2.7%
5/12 Sensus Healthcare's (SRTS) CEO Joe Sardano on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 2.6%
8/12 Sensus Healthcare Inc (NASDAQ: SRTS) was given a new $11.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 2.6%
9/20 Sensus Healthcare Inc (NASDAQ: SRTS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 1.8%
10/18 Sensus Healthcare Inc (NASDAQ: SRTS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 1.8%
11/10 Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 1.6%
5/24 Sensus Healthcare Inc (NASDAQ: SRTS) was downgraded by analysts at TheStreet from a "c-" rating to a "d+" rating. 1.3%
TOP News Decliners
11/6
Q3/2019 9/30/2019 EPS -0.040 ZacksConsensus -0.050 ActVsEst 0.010 - Beat
-29.4%
5/9 Q1/2019 3/31/2019 EPS -0.130 ZacksConsensus -0.020 ActVsEst (0.110) - Miss -15.7%
3/6 Form 10-K Sensus Healthcare, Inc. For: Dec 31 -9.3%
2/13 Form 8-K Sensus Healthcare, Inc. For: Feb 13 -7.2%
6/10 Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference -5.8%
11/8 Form 10-Q Sensus Healthcare, Inc. For: Sep 30 -5.2%
4/29 Form DEF 14A Sensus Healthcare, Inc. For: Jun 05 -3.2%
5/14 Form 10-Q Sensus Healthcare, Inc. For: Mar 31 -2.9%
11/21 Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference -2.5%
1/6 Sensus Healthcare Announces Management Promotions -2.2%
5/9 Q1/2019 3/31/2019 EPS -0.130 ZacksConsensus -0.020 ActVsEst (0.110) - Miss -15.7%
3/6 Form 10-K Sensus Healthcare, Inc. For: Dec 31 -9.3%
2/13 Form 8-K Sensus Healthcare, Inc. For: Feb 13 -7.2%
6/10 Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference -5.8%
11/8 Form 10-Q Sensus Healthcare, Inc. For: Sep 30 -5.2%
4/29 Form DEF 14A Sensus Healthcare, Inc. For: Jun 05 -3.2%
5/14 Form 10-Q Sensus Healthcare, Inc. For: Mar 31 -2.9%
11/21 Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference -2.5%
1/6 Sensus Healthcare Announces Management Promotions -2.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: